Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2000
06/02/2000WO2000030622A2 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
06/02/2000WO2000030614A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state
06/02/2000WO2000030613A1 New process
06/02/2000WO2000010999A3 New compounds
06/02/2000WO2000009156A9 Non-virulent porphyromonas gingivalis mutant
06/02/2000CA2352963A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352493A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease
06/02/2000CA2352477A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000CA2352278A1 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
06/02/2000CA2352144A1 Scavenger compounds
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
06/02/2000CA2351719A1 Pharmaceutical compositions containing olanzapine-n-oxide
06/02/2000CA2351718A1 Desmethylolanzapine compositions and methods
06/02/2000CA2351679A1 Prostaglandin conjugates for treating or preventing bone disease
06/02/2000CA2351630A1 Vector
06/02/2000CA2351446A1 Benzoxazole derivatives and medicaments comprising said derivatives as active ingredient
06/02/2000CA2351361A1 Gtpase associated proteins
06/02/2000CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000CA2350969A1 Compounds having cytokine inhibitory activity
06/02/2000CA2347940A1 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/2000
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004598A2 Coated carrier materials for the purification of blood, plasma and tissues, and columns comprising said carrier materials
05/31/2000EP1004584A2 Pyranoquinoline derivatives as inhibitors of cell proliferation
05/31/2000EP1004578A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
05/31/2000EP1004311A1 Evacuant comprising magnesium oxide
05/31/2000EP1004300A1 Anion regulator for ruminants
05/31/2000EP1003857A2 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003846A1 Protease inhibitors
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003776A1 Gene and amino acid sequences for novel transcription factor
05/31/2000EP1003775A2 Hepatitis c inhibitor peptides
05/31/2000EP1003770A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003749A1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h/2,3/BENZODIAZEPINE DERIVATES, AS AMPA/KAINATERECEPTOR INHIBITORS
05/31/2000EP1003748A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/31/2000EP1003744A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
05/31/2000EP1003740A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists
05/31/2000EP1003739A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives
05/31/2000EP1003738A1 Bicyclic compounds as ligands for 5-ht1 receptors
05/31/2000EP1003728A1 2- 3- 4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto pyrimidin-4-ol-fumarate
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003713A1 Anthranilic acid analogs
05/31/2000EP1003524A1 New formulation
05/31/2000EP1003523A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein
05/31/2000EP1003509A1 Il-8 receptor antagonists
05/31/2000EP1003505A1 Heterocyclic vinylethers against neurological disorders
05/31/2000EP1003504A2 Indole derivatives and their use as mcp-1 antagonists
05/31/2000EP1003497A1 Il-8 receptor antagonists
05/31/2000EP0794942B1 Substituted biphenyl compounds for the treatment of inflammation
05/31/2000EP0793495B1 Freeze-dried ondansetron compositions
05/31/2000DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs
05/31/2000CN1255162A Protease inhibitors
05/31/2000CN1255161A Protease inhibitors
05/31/2000CN1255119A Protease inhibitors
05/31/2000CN1255117A Excitatory amino acid receptor modulators
05/31/2000CN1255063A Photosensitizer conjugates for pathogen targeting
05/31/2000CN1254592A Health-care bag tea
05/31/2000CN1254588A Life-elongating health-care medicinal pill
05/31/2000CN1254585A Chinese medicine for radically treating hepatitis A
05/31/2000CN1254574A Inflammation-relieving antipyretic syrup
05/31/2000CN1254563A Medicine for treating odontopathy
05/31/2000CN1052979C Carbazolone derivatives and process for preparing same
05/31/2000CN1052913C Medicine for treating hepatitis A and its preparing process
05/31/2000CN1052906C External application medicine for treating toothache due to saprodontia
05/31/2000CN1052894C Kinetogenesis Chinese medicine for gastrointestinal tract
05/31/2000CN1052891C Gargle for aphtha
05/31/2000CN1052889C Chinese proprietary medicine for curing hepatitis
05/31/2000CN1052886C Chinese drug powder for curing heaptitis B and its preparing method
05/31/2000CN1052882C Multipurpose inner coating agent for tooth
05/30/2000US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
05/30/2000US6069154 In humans; side effect reduction
05/30/2000US6069152 Nervous system disorders; cardiovascular disorders; gastrointestinal disorders
05/30/2000US6069150 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
05/30/2000US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease
05/30/2000US6068856 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
05/30/2000US6068841 Antibodies to Fas-L for treatment of hepatitis
05/30/2000CA2014889C Intra-rectal pharmaceutical foam compositions
05/25/2000WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species
05/25/2000WO2000029588A1 Lysozyme fusion proteins in infections
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029581A1 Human tslp dna and polypeptides
05/25/2000WO2000029574A2 Inflammation-associated genes
05/25/2000WO2000029569A1 Methods of diagnosing or treating neurological diseases
05/25/2000WO2000029447A1 Rhamm antagonist antibodies
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029405A1 Method for preparing (2s)-1-[ (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide
05/25/2000WO2000029403A1 Novel pyrimidine derivatives and processes for the preparation thereof
05/25/2000WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/25/2000WO2000029381A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
05/25/2000WO2000029371A1 Excitatory amino acid receptor modulators
05/25/2000WO2000029011A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
05/25/2000WO2000028988A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
05/25/2000WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives
05/25/2000WO2000028977A1 Antioxidant gel for gingival conditions
05/25/2000WO2000028975A2 Improved chemical process and pharmaceutical formulation
1 ... 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 ... 1258